VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines

被引:1996
作者
Doytchinova, Irini A.
Flower, Darren R.
机构
[1] Med Univ Sofia, Fac Pharm, Sofia 1000, Bulgaria
[2] Univ Oxford, Jenner Inst, Compton RG20 7NN, Berks, England
关键词
D O I
10.1186/1471-2105-8-4
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Background: Vaccine development in the post-genomic era often begins with the in silico screening of genome information, with the most probable protective antigens being predicted rather than requiring causative microorganisms to be grown. Despite the obvious advantages of this approach - such as speed and cost efficiency - its success remains dependent on the accuracy of antigen prediction. Most approaches use sequence alignment to identify antigens. This is problematic for several reasons. Some proteins lack obvious sequence similarity, although they may share similar structures and biological properties. The antigenicity of a sequence may be encoded in a subtle and recondite manner not amendable to direct identification by sequence alignment. The discovery of truly novel antigens will be frustrated by their lack of similarity to antigens of known provenance. To overcome the limitations of alignment-dependent methods, we propose a new alignment-free approach for antigen prediction, which is based on auto cross covariance (ACC) transformation of protein sequences into uniform vectors of principal amino acid properties. Results: Bacterial, viral and tumour protein datasets were used to derive models for prediction of whole protein antigenicity. Every set consisted of 100 known antigens and 100 non-antigens. The derived models were tested by internal leave-one-out cross-validation and external validation using test sets. An additional five training sets for each class of antigens were used to test the stability of the discrimination between antigens and non-antigens. The models performed well in both validations showing prediction accuracy of 70% to 89%. The models were implemented in a server, which we call VaxiJen. Conclusion: VaxiJen is the first server for alignment-independent prediction of protective antigens. It was developed to allow antigen classification solely based on the physicochemical properties of proteins without recourse to sequence alignment. The server can be used on its own or in combination with alignment-based prediction methods. It is freely-available online at the URL: http://www.jenner.ac.uk/VaxiJen.
引用
收藏
页数:7
相关论文
共 23 条
[1]
Ada G. L, 1997, NEW GENERATION VACCI, P13
[2]
BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[3]
Preprocessing peptide sequences for multivariate sequence-property analysis [J].
Andersson, PM ;
Sjostrom, M ;
Lundstedt, T .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1998, 42 (1-2) :41-50
[4]
[Anonymous], 2004, Protein structure and function
[5]
Improved prediction of signal peptides: SignalP 3.0 [J].
Bendtsen, JD ;
Nielsen, H ;
von Heijne, G ;
Brunak, S .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 340 (04) :783-795
[6]
The use of the area under the roc curve in the evaluation of machine learning algorithms [J].
Bradley, AP .
PATTERN RECOGNITION, 1997, 30 (07) :1145-1159
[7]
Towards the chemometric dissection of peptide - HLA-A*0201 binding affinity: comparison of local and global QSAR models [J].
Doytchinova, IA ;
Walshe, V ;
Borrow, P ;
Flower, DR .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2005, 19 (03) :203-212
[8]
FLOYD RW, 1969, COMMUN ACM, V12, P345
[9]
Analysis of peptide-protein binding using amino acid descriptors: Prediction and experimental verification for human histocompatibility complex HLA-A*0201 [J].
Guan, PP ;
Doytchinova, IA ;
Walshe, VA ;
Borrow, P ;
Flower, DR .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) :7418-7425
[10]
PEPTIDE QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS, A MULTIVARIATE APPROACH [J].
HELLBERG, S ;
SJOSTROM, M ;
SKAGERBERG, B ;
WOLD, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (07) :1126-1135